Leading global VC and PE firm, Insight Partners, has recently announced that it will invest $7.5 million in Apprentice.io, to scale its solutions to help life sciences firms meet market demands.

Apprentice.io is an intelligent software company that builds solutions for global life science teams to increase speed to market, improve product yield and decrease deviations so that critical drugs get to market faster, with higher reliability.

Since the Covid-19 outbreak, Apprentice has experienced:

• 15x increase in usage as many life sciences organizations are working on potential vaccines and special treatments for the pandemic
• 6x increase in side deployments since March due to its ability to providing a secure platform for suppliers, pharma teams, subject experts and others

Apprentice’s solutions include an augmented reality, language-independent collaboration tool and an intelligent software platform.

Source: Insight Partners

‍